Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 1,750 | 3,544 | 2,214 | 1,968 | 2,376 |
| Cost of Goods | 828 | 1,392 | 995 | 764 | 1,136 |
| Gross Profit | 921 | 2,152 | 1,219 | 1,205 | 1,240 |
| Operating Expenses | 2,015 | 1,626 | 2,095 | 1,918 | 1,354 |
| Operating Income | -265 | 918 | 119 | 51 | 22 |
| Other Income | -36 | -30 | -51 | -27 | -31 |
| Pre-tax Income | -302 | 888 | 69 | 24 | -10 |
| Income Tax | -83 | 304 | 38 | -11 | -1 |
| Net Income Continuous | -218 | 584 | 30 | 35 | -9 |
| Net Income | $-218 | $584 | $30 | $35 | $-9 |
| EPS Basic Total Ops | -0.05 | 0.12 | -0.01 | 0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.05 | 0.12 | 0.00 | 0.01 | 0.00 |
| EPS Diluted Total Ops | -0.05 | 0.12 | N/A | 0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.05 | 0.12 | 0.00 | 0.01 | 0.00 |
| EBITDA(a) | $-53 | $1,137 | $337 | $251 | $233 |